Back to top

Image: Bigstock

Strong Demand, Higher Prices to Aid Reliance Steel (RS)

Read MoreHide Full Article

We issued an updated research report on metals service center company, Reliance Steel & Aluminum Co (RS - Free Report) on Oct 16.

Reliance Steel is gaining from its broad and diversified product base, wide geographic footprint and continued demand strength across aerospace and automotive markets and synergies of acquisitions. The company continues with its aggressive acquisition strategy to tap growth opportunities.

The company, during its second-quarter call, said that it is optimistic about business conditions for the third quarter and sees continued improvement in the end markets in which it operates. The company expects demand to remain strong in the third quarter.

Demand in the aerospace market has been driven by higher commercial aerospace build rates. Strong demand is also witnessed in the automotive market, backed by increased use of aluminum in the industry.

Reliance Steel is also expected to continue to benefit from a favorable metal pricing environment. The company’s average selling price per ton sold rose 9.6% on a sequential comparison basis in the second quarter, exceeding its expectations of 5-8% increase. The metal pricing environment drove pricing levels in each month of the quarter, contributing to the company’s earnings. Strong demand coupled with Section 232 trade actions on imported steel led to higher pricing in the second quarter.

The Trump administration’s Section 232 actions have provided much-needed protection to the American steel producers including Nucor Corporation (NUE - Free Report) , United States Steel Corporation (X - Free Report) and AK Steel Holding Corporation which had long struggled to cope with a tide of subsidized foreign imports. The tariffs are leading to lower imports into the United States and have provided a boost to U.S. steel prices.

Reliance Steel expects average selling price per ton to be up 1% to 3% in the third quarter from the second. This should support its margins in the third quarter.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>
 


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


United States Steel Corporation (X) - free report >>

Nucor Corporation (NUE) - free report >>

Reliance, Inc. (RS) - free report >>

Published in